Home /Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial

Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial

Submitted by dcc on Mon, 02/14/2022 - 15:17
TitleOlaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial
Publication TypeJournal Article
Year of Publication2021
AuthorsFujiwara, K, Fujiwara, H, Yoshida, H, Satoh, T, Yonemori, K, Nagao, S, Matsumoto, T, Kobayashi, H, Bourgeois, H, Harter, P, Mosconi, AMaria, Vazquez, IPalacio, Reinthaller, A, Fujita, T, Rowe, P, Pujade-Lauraine, E, Ray-Coquard, I
JournalJournal of Gynecologic Oncology
Volume32
Issue5
Date PublishedJan-01-2021
ISSN2005-0380
URLhttps://ejgo.org/DOIx.php?id=10.3802/jgo.2021.32.e82https://ejgo.org/DOIx.php?id=10.3802/jgo.2021.32.e82https://ejgo.org/pdf/10.3802/jgo.2021.32.e82https://ejgo.org/DOIx.php?id=10.3802/jgo.2021.32.e82
DOI10.3802/jgo.2021.32.e82
Short TitleJ Gynecol Oncol